Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Tamsulosin for Ureteral Stones
NCT06999135Completed
- Sponsor
- Fatima Jinnah Medical University
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of silodosin in ureterolithiasis (2 arms), sponsored by Fatima Jinnah Medical University. Primary endpoints: Stone Expulsion Rate at 6 months and Time to Stone Expulsion at 6 months. Started Oct 2023; status: completed.
02
Drugs
silodosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on NCT06999135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999135.